BC ADM Cardiometabolic Conditions & Comorbidity Management — Questions and Answers
Question 1: A 58-year-old patient with type 2 diabetes has blood pressure readings of 142/88 mmHg at two separate clinic visits. According to ADA Standards of Medical Care, what is the recommended blood pressure target for most patients with diabetes and hypertension?
- Less than 140/90 mmHg
- Less than 130/80 mmHg (Correct answer)
- Less than 120/70 mmHg
- Less than 150/90 mmHg
Correct answer: Less than 130/80 mmHg
The ADA recommends a blood pressure target of <130/80 mmHg for most patients with diabetes and hypertension, as this threshold is associated with reduced risk of cardiovascular events, stroke, and nephropathy progression compared to the older <140/90 target.
Question 2: Which antihypertensive medication class is considered first-line for a patient with type 2 diabetes, hypertension, and persistent albuminuria (urine albumin-to-creatinine ratio >300 mg/g)?
- Thiazide diuretics
- Beta-blockers
- ACE inhibitors or ARBs (Correct answer)
- Calcium channel blockers
Correct answer: ACE inhibitors or ARBs
ACE inhibitors and ARBs are first-line for patients with diabetes and albuminuria because they reduce intraglomerular pressure and have nephroprotective effects beyond their antihypertensive action, slowing progression of diabetic kidney disease.
Question 3: A patient with type 2 diabetes and established atherosclerotic cardiovascular disease (ASCVD) is being evaluated for statin therapy. What is the recommended LDL-C goal or reduction target according to current ADA guidelines?
- Reduce LDL-C by at least 30%
- Achieve LDL-C below 100 mg/dL
- Reduce LDL-C by at least 50% or achieve LDL-C below 70 mg/dL (Correct answer)
- Achieve LDL-C below 55 mg/dL regardless of baseline
Correct answer: Reduce LDL-C by at least 50% or achieve LDL-C below 70 mg/dL
For patients with diabetes and established ASCVD (very high risk), the ADA recommends high-intensity statin therapy with a goal of ≥50% LDL-C reduction OR an LDL-C below 70 mg/dL. If this target is not achieved with maximally tolerated statin therapy, adding ezetimibe or a PCSK9 inhibitor may be considered.
Question 4: A patient with type 2 diabetes and heart failure with reduced ejection fraction (HFrEF, EF 35%) needs improved glycemic control. Which medication class is recommended by both ADA and cardiology guidelines for dual benefit in glycemic control and heart failure outcomes?
- GLP-1 receptor agonists
- Sulfonylureas
- SGLT2 inhibitors (Correct answer)
- DPP-4 inhibitors
Correct answer: SGLT2 inhibitors
SGLT2 inhibitors (empagliflozin, dapagliflozin) have demonstrated significant reductions in heart failure hospitalizations and cardiovascular mortality in patients with HFrEF in landmark trials (EMPEROR-Reduced, DAPA-HF), in addition to their glucose-lowering effects. They are now recommended by both ADA and cardiology guidelines for this population.
Question 5: A patient with type 2 diabetes presents with a fasting triglyceride level of 540 mg/dL. Before initiating statin therapy for cardiovascular risk reduction, what is the primary treatment priority?
- Initiate high-intensity statin therapy immediately to reduce ASCVD risk
- Lower triglycerides first to reduce the risk of acute pancreatitis (Correct answer)
- Refer to endocrinology before any treatment
- Start a fibrate and a statin simultaneously
Correct answer: Lower triglycerides first to reduce the risk of acute pancreatitis
When triglycerides exceed 500 mg/dL, the immediate priority is reducing triglyceride levels to prevent acute pancreatitis, a serious and potentially life-threatening complication. Fibrates or high-dose omega-3 fatty acids are first-line for severe hypertriglyceridemia. Statin therapy for ASCVD risk reduction becomes the focus once triglycerides are below 500 mg/dL.
Question 6: According to ADA Standards, which of the following patients with type 2 diabetes should be considered for aspirin therapy (75–162 mg/day) for primary prevention of cardiovascular disease?
- All patients with type 2 diabetes over age 40
- Patients with type 2 diabetes at high cardiovascular risk (10-year CVD risk >10%) who are not at increased bleeding risk (Correct answer)
- Patients with type 2 diabetes who have had an A1C above 8% for more than 2 years
- Patients with type 2 diabetes and microalbuminuria regardless of CVD risk
Correct answer: Patients with type 2 diabetes at high cardiovascular risk (10-year CVD risk >10%) who are not at increased bleeding risk
Current ADA guidelines recommend aspirin for primary prevention only in patients with diabetes at high CVD risk (10-year risk >10%), typically including many men over 50 and women over 60 with additional risk factors. Aspirin is not recommended for low- or moderate-risk patients due to evidence that bleeding risks may offset cardiovascular benefits in primary prevention.
BC ADM Cardiometabolic Conditions & Comorbidity Management
A 58-year-old patient with type 2 diabetes has blood pressure readings of 142/88 mmHg at two separate clinic visits.
According to ADA Standards of Medical Care, what is the recommended blood pressure target for most patients with diabetes and hypertension?